trial

The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia

NCTId NCT03077347
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 6 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2023-02-23
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
6 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2017-04-01
Primary completion
2023-02-23
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
transcranial direct current stimulation

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Investigators

1
Cameron Carter, M.D.Study Director

Sites

1 total
Sacramento, United States

Facts & assertions

4 sourced
Enrollment
6
Phase
NA
Primary Completion Date
2023-02-23
Status
TERMINATED
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Cameron Carter, M.D.
person